Hillman Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,106
Closed -$2.55M – 57
2026
Q2
$2.55M Sell
7,106
-1,800
-20% -$550K 1.85% 23
2026
Q1
$2.23M Hold
8,906
– – 1.55% 34
2025
Q4
$2.45M Sell
8,906
-1,367
-13% -$374K 1.54% 36
2025
Q3
$2.69M Buy
+10,273
New +$2.5M 1.57% 36

Other funds holding WST

Hillman Capital Management's WST Position: Q3 2026 in Review

Hillman Capital Management sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 7,106 shares — an estimated $2.55M sold.

Hillman Capital Management first reported a position in WST in Q3 2025 and held it in 4 quarters. The position peaked at $2.69M in Q3 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Hillman Capital Management reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Hillman Capital Management sold 7,106 West Pharmaceutical shares in Q3 2026, an estimated $2.55M.
  • Hillman Capital Management first reported a position in West Pharmaceutical in Q3 2025 and held it in 4 quarters.
  • Hillman Capital Management's West Pharmaceutical position peaked at $2.69M in Q3 2025.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Hillman Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.